Back to mobile site

MannKind to acquire scPharmaceuticals for up to $360 million

August 25, 2025 7:30 AM EDT Send to a Friend
MannKind Corporation (NASDAQ: MNKD) announced a definitive merger agreement to acquire scPharmaceuticals Inc. (NASDAQ: SCPH) for $5.35 per share in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login